Hoja de datos para pacientes y padres/cuidadores Autorizacion para el uso de emergencia (EUA) de remdesivir para la enfermedad por coronavirus 2019 (COVID-19)

Text Registration

Hoja de datos para pacientes y padres/cuidadores Autorizacion para el uso de emergencia (EUA) de remdesivir para la enfermedad por coronavirus 2019 (COVID-19)

Status

Published

on 21 May 2020

Year of Creation

2020

Gilead Sciences, Inc

Registration Number

TX0008871711

on 21 May 2020

The U.S. Copyright record (Registration Number: TX0008871711) dated 21 May 2020, pertains to an electronic file (eService) titled "Hoja de datos para pacientes y padres/cuidadores Autorizacion para el uso de emergencia (EUA) de remdesivir para la enfermedad por coronavirus 2019 (COVID-19)" created in 2020. The copyright holder is Gilead Sciences, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Gilead Sciences, Inc.

Gilead Sciences, Inc

Application Details

Registration Number

TX0008871711

Registration Date

5/21/2020

Year of Creation

2020

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Gilead Sciences, Inc

Physical Description

Electronic file (eService)

First Publication Nation

United States

Preexisting Material

text

Corporate Authors

Inc Gilead Sciences

Notes

Rights Note: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, tmteam@gilead.com

Local Copyright Note: C.O. correspondenceRegarding previous registration: Registration number added from C.O. records

Material Matter Claimed Note: translation

Previous Registration Note: 2020, TX0008870868

Statements

Application Title Statement: Hoja de datos para pacientes y padres/cuidadores Autorizacion para el uso de emergencia (EUA) de remdesivir para la enfermedad por coronavirus 2019 (COVID-19)

Author Statement: Gilead Sciences, Inc employer for hire Domicile: United States Authorship: translation

Notes

Rights Note: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA, 94404, tmteam@gilead.com

Local Copyright Note: C.O. correspondenceRegarding previous registration: Registration number added from C.O. records

Material Matter Claimed Note: translation

Previous Registration Note: 2020, TX0008870868

Statements

Application Title Statement: Hoja de datos para pacientes y padres/cuidadores Autorizacion para el uso de emergencia (EUA) de remdesivir para la enfermedad por coronavirus 2019 (COVID-19)

Author Statement: Gilead Sciences, Inc employer for hire Domicile: United States Authorship: translation

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.